BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, March 15, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 7, 2016
View Archived Issues
BioPharmX initiates phase IIa study of BPX-01 for acne
Read More
First patient dosed in phase I trial of BAX-826 for the treatment of hemophilia A
Read More
Akinion ceases further development of AKN-028 due to safety concerns
Read More
EMA grants eligibility for submission of XBiotech's MAA for Xilonix
Read More
APO-010 screening protocol approved by ethics committee
Read More
Lessons learned from nonrandomized trial of favipiravir in patients with Ebola virus disease
Read More
Novartis initiates phase I trial of LXS-196 for metastatic uveal melanoma
Read More
Novel mutations in TNNT1 gene described as cause of myopathies
Read More
UCLA sells Xtandi royalty rights to Royalty Pharma
Read More
Bristol-Myers Squibb patent describes S1P1 receptor agonists
Read More
University of Washington patents methionyl-tRNA synthetase inhibitors
Read More
PTC Therapeutics divulges anti-infective agents
Read More
FDA approves Imbruvica for first-line treatment of CLL
Read More
FDA approves Idelvion for hemophilia B
Read More
Antibe Therapeutics cleared to begin phase II study of ATB-346
Read More
PeptiDream and Lilly in technology license agreement
Read More
U.S. fast track designation granted to MEDI-8852 for patients with type A strain influenza
Read More
Merck & Co. and Mectizan Donation Program donate to END fund
Read More
Total levels of IgE are elevated in patients with hidradenitis suppurativa
Read More
Oxford BioMedica and Immune Design in expanded collaboration and license agreement
Read More
LEADER trial demonstrates cardiovascular benefit of Victoza
Read More
3SBio obtains IND clearance in China for PEG-irinotecan
Read More
Plexxikon initiates phase I study of PLX-73086
Read More
EMA launches new PRIME program
Read More
